Navigation Links
SynergEyes Reports Minor Interruption at Manufacturing Facility
Date:10/24/2013

CARLSBAD, Calif., Oct. 24, 2013 /PRNewswire/ -- SynergEyes, manufacturer and marketer of hybrid contact lenses, reported a minor interruption at its manufacturing facility in the 2200 block of Rutherford Road on Tuesday, October 22nd. The disruption occurred when a small amount of vapor was released inside the building due to a chemical reaction of an unknown cause. The facility was immediately evacuated and the Carlsbad Fire Department notified.

(Logo: http://photos.prnewswire.com/prnh/20131024/LA04236LOGO)

The fire department quickly neutralized the source of the vapor and cleared the facility for re-entry. There was no chemical spill of any kind and no injuries to SynergEyes employees or anyone in adjoining buildings. The Carlsbad Fire Department believes there was no threat of environmental damage as a result of the incident.

"We have a safety system for dealing with hazardous waste and that system operated exactly as it was designed to do. It contained the chemicals, with no spills or leaks whatsoever, and vented the fumes to prevent any other danger," said Steve Ziemba, Vice President of Quality and Clinical Affairs. "We evacuated the building and contacted the Carlsbad Fire Department due to an abundance of caution when the incident was discovered and are pleased that there were no adverse events resulting from this."

The company resumed manufacturing operations today and will continue to investigate the cause of the event.

"We are committed to operating a safe work environment and take all practical precautions to ensure that hazards and accidents do not occur," says Dr. James K. Kirchner, President and CEO of SynergEyes. "Although this incident did not result in any personal injury or put the local community in jeopardy, we consider this to be a serious matter and pledge to take any and all corrective action necessary to prevent future mishaps."

Headquartered in Carlsbad, California, SynergEyes, Inc. was founded in 2001 to develop a contact lens that would combine the superior visual quality of a gas permeable lens with the comfort and ease of wear of a soft contact lens. The revolutionary SynergEyes hybrid contact lenses allow patients to enjoy the best of both worlds – consistently crisp vision and all-day comfort. SynergEyes holds numerous U.S. patents, along with FDA market clearances for the entire family of SynergEyes, Duette and UltraHealth contact lenses. The patented SynergEyes technology is currently available through more than 5,000 eye care practitioners worldwide.


'/>"/>
SOURCE SynergEyes
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
2. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
3. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
4. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
5. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
6. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
7. PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results
8. Luminex Corporation Reports First Quarter 2012 Results
9. Hospira Reports First-Quarter 2012 Results
10. Endo Reports First Quarter Financial Results And Announces Return To Steady Supply Of OPANA® ER And Voltaren® Gel
11. The Female Health Company Reports Second Quarter Operating Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... -- Research and Markets has announced the addition ... their offering. ... The report forecasts the global optical transceiver market to grow at ... The report covers the present scenario and the growth prospects of ... size, the report considers the revenue generated from the shipment of ...
(Date:12/9/2016)... , Dec. 9, 2016  RxWiki Inc., a ... and digital marketing strategies of thousands of pharmacies through ... won Austin Inno,s "50 on Fire" Award ... "We,re pleased to accept the award as one ... , Chief Executive Officer at RxWiki. "Our platform gives ...
(Date:12/8/2016)... 8, 2016 IRIDEX Corporation (NASDAQ: IRIX ... shares of common stock, $0.01 par value (the "Offering" with ... offering.  The final terms of the Offering will depend on ... there can be no assurance as to whether or when ... use the net proceeds it will receive from this offering ...
Breaking Medicine Technology:
(Date:12/9/2016)... New York, NY (PRWEB) , ... December 09, 2016 , ... ... that raises awareness for organ transplantation while encouraging readers to sign up as an ... for a lifesaving organ transplant. , An organ donor can save up to ...
(Date:12/9/2016)... ... 2016 , ... "I had a terrible time trying to get my grandson ... if the nebulizer had a more child-friendly design, then children would be more likely ... patent-pending NEBY to avoid the need to deliver medication via a nebulizer mask. The ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... distinction by the Undersea and Hyperbaric Medical Society (UHMS), the leading authority in ... and patient safety. Only a few hospitals and facilities have earned this distinction. ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... pleased to announce that “Natural Language Processing–Enabled and Conventional Data Capture Methods for ... JMIR Medical Informatics . , Results of the comparative usability study demonstrate ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... CURE Media ... centers and advocacy groups, has aligned with Upstage Lung Cancer in efforts to combat ... the announcement, Michael J. Hennessy, Jr said, “CURE Media Group is honored to team ...
Breaking Medicine News(10 mins):